Many population-based analyses suggest that gonadotropin-releasing hormone (GnRH) agonist use is associated with a greater risk of coronary artery disease, myocardial infarction, and diabetes mellitus (DM) [17–19]. The gene discussed is GNRH1; the disease is coronary artery disorder.